🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a prospective one-arm, two-stage phase 2 trial of TVB-2640 in KRAS ...
Status
Active Not Recruiting
Location
University of Cincinnati
Start Date
2019-09-11
Trial ID
NCT03808558
Treatments Being Tested
Ascending oral single-dose study to evaluate the safety and pharmacokinetic...
Status
Completed
Location
Hunan provincial people's hospital
Start Date
2020-04-02
Trial ID
NCT04352361
This first in human phase 1 study of TVB-2640 is being conducted in patient...
Status
Completed
Location
Multiple Locations
Start Date
2013-11
Trial ID
NCT02223247
Treatments Being Tested
The goal of this phase 1 study is to assess the pharmacokinetics, safety an...
Status
Completed
Location
Thomas C. Marbury
Start Date
2023-05-01
Trial ID
NCT05835180
Treatments Being Tested
This is a randomized, double-blind, controlled and multi-center Phase III c...
Status
Active Not Recruiting
Location
Beijing Tiantan Hospital，Capital Medical University
Start Date
2022-01-21
Trial ID
NCT05118776
Treatments Being Tested
This is a Phase 2 multi-center, randomized, single-blind, placebo-controlle...
Status
Completed
Location
ProSciento
Start Date
2019-03-22
Trial ID
NCT03938246
The purpose of this study is to determine what effects (good and bad) Enzal...
Status
Recruiting
Location
Weill Cornell Medicine/NewYork-Presbyterian Hospital
Start Date
2023-11-20
Trial ID
NCT05743621
Treatments Being Tested
A phase 3, randomized, double-blind, placebo-controlled study evaluating th...
Status
Withdrawn
Location
Multiple Locations
Start Date
2025-03
Trial ID
NCT06692283
Treatments Being Tested
This phase II trial studies how well FASN inhibitor TVB-2640, paclitaxel, a...
Status
Completed
Location
Mayo Clinic in Arizona
Start Date
2017-08-03
Trial ID
NCT03179904
A Phase 1, Open-label Study of the absorption, metabolism, and excretion of...
Status
Completed
Location
Celerion Inc.
Start Date
2022-11-21
Trial ID
NCT05657834
Treatments Being Tested